Financial information regarding reportable operating segments |
Summarized financial information regarding our reportable operating segments for the three months ended March 31, 2025 and 2024 is shown in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In millions |
|
Engine |
|
Components |
|
|
|
Distribution |
|
|
|
Power Systems |
|
Accelera |
|
Total Segments |
|
|
|
|
Three months ended March 31, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
$ |
2,040
|
|
|
$ |
2,270
|
|
|
|
|
$ |
2,902
|
|
|
|
|
$ |
872
|
|
|
$ |
90
|
|
|
$ |
8,174
|
|
|
|
|
|
Intersegment sales |
|
731
|
|
|
400
|
|
|
|
|
5
|
|
|
|
|
777
|
|
|
13
|
|
|
1,926
|
|
|
|
|
|
Total sales |
|
2,771
|
|
|
2,670
|
|
|
|
|
2,907
|
|
|
|
|
1,649
|
|
|
103
|
|
|
10,100
|
|
|
|
|
|
Cost of goods sold (excluding warranty expenses) |
|
2,036
|
|
|
2,139
|
|
|
|
|
2,332
|
|
|
|
|
1,090
|
|
|
121
|
|
|
7,718
|
|
|
|
|
|
Warranty expenses |
|
85
|
|
|
26
|
|
|
|
|
6
|
|
|
|
|
32
|
|
|
8
|
|
|
157
|
|
|
|
|
|
Selling expenses |
|
59
|
|
|
41
|
|
|
|
|
157
|
|
|
|
|
46
|
|
|
7
|
|
|
310
|
|
|
|
|
|
Administrative expenses |
|
138
|
|
|
119
|
|
|
|
|
91
|
|
|
|
|
100
|
|
|
13
|
|
|
461
|
|
|
|
|
|
Research, development and engineering expenses |
|
155
|
|
|
75
|
|
|
|
|
14
|
|
|
|
|
57
|
|
|
43
|
|
|
344
|
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
73
|
|
|
7
|
|
|
|
|
28
|
|
|
|
|
29
|
|
|
(6) |
|
|
131
|
|
|
|
|
|
Other income (expense) (1)
|
|
20
|
|
|
(17) |
|
|
|
|
9
|
|
|
|
|
3
|
|
|
(3) |
|
|
12
|
|
|
|
|
|
Add back: Depreciation and amortization (2)
|
|
67
|
|
|
122
|
|
|
|
|
32
|
|
|
|
|
33
|
|
|
12
|
|
|
266
|
|
|
|
|
|
Segment EBITDA |
|
$ |
458
|
|
|
$ |
382
|
|
|
|
|
$ |
376
|
|
|
|
|
$ |
389
|
|
|
$ |
(86) |
|
|
$ |
1,519
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income (3)
|
|
$ |
10
|
|
|
$ |
7
|
|
|
|
|
$ |
5
|
|
|
|
|
$ |
4
|
|
|
$ |
—
|
|
|
$ |
26
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, 2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
$ |
2,240 |
|
|
$ |
2,842 |
|
|
|
|
$ |
2,529 |
|
|
|
|
$ |
708 |
|
|
$ |
84 |
|
|
$ |
8,403 |
|
|
|
|
|
Intersegment sales |
|
688 |
|
|
490 |
|
|
|
|
6 |
|
|
|
|
681 |
|
|
9 |
|
|
1,874 |
|
|
|
|
|
Total sales |
|
2,928 |
|
|
3,332 |
|
|
|
|
2,535 |
|
|
|
|
1,389 |
|
|
93 |
|
|
10,277 |
|
|
|
|
|
Cost of goods sold (excluding warranty expenses) |
|
2,190 |
|
|
2,636 |
|
|
|
|
2,046 |
|
|
|
|
997 |
|
|
120 |
|
|
7,989 |
|
|
|
|
|
Warranty expenses |
|
105 |
|
|
62 |
|
|
|
|
5 |
|
|
|
|
15 |
|
|
8 |
|
|
195 |
|
|
|
|
|
Selling expenses |
|
52 |
|
|
55 |
|
|
|
|
153 |
|
|
|
|
40 |
|
|
8 |
|
|
308 |
|
|
|
|
|
Administrative expenses |
|
144 |
|
|
158 |
|
|
|
|
91 |
|
|
|
|
99 |
|
|
13 |
|
|
505 |
|
|
|
|
|
Research, development and engineering expenses |
|
154 |
|
|
84 |
|
|
|
|
14 |
|
|
|
|
60 |
|
|
55 |
|
|
367 |
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
57 |
|
|
26 |
|
|
|
|
24 |
|
|
|
|
19 |
|
|
(3) |
|
|
123 |
|
|
|
|
|
Other income (expense) (1)
|
|
16 |
|
|
(15) |
|
|
|
|
13 |
|
|
|
|
6 |
|
|
(1) |
|
|
19 |
|
|
|
|
|
Add back: Depreciation and amortization (2)
|
|
58 |
|
|
125 |
|
|
|
|
31 |
|
|
|
|
34 |
|
|
14 |
|
|
262 |
|
|
|
|
|
Segment EBITDA |
|
$ |
414 |
|
|
$ |
473 |
|
(4) |
|
|
$ |
294 |
|
|
|
|
$ |
237 |
|
|
$ |
(101) |
|
|
$ |
1,317 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income (3)
|
|
$ |
7 |
|
|
$ |
8 |
|
|
|
|
$ |
11 |
|
|
|
|
$ |
3 |
|
|
$ |
— |
|
|
$ |
29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Other income (expense) includes other operating expense, net and other income, net from our Condensed Consolidated Statements of Net Income.
|
(2) Depreciation and amortization are not considered significant segment expenses but are presented here to reconcile to EBITDA, the measure used by our CODM. Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our Condensed Consolidated Statements of Net Income as interest expense. The amortization of debt discount and deferred costs was $3 million and $3 million for the three months ended March 31, 2025 and March 31, 2024, respectively. A portion of depreciation expense is included in research, development and engineering expenses.
|
(3) Interest income is a component of other income (expense).
|
(4) Included $21 million of costs associated with the divestiture of Atmus for the three months ended March 31, 2024. See NOTE 14, "ATMUS DIVESTITURE," for additional information.
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of segment information |
A reconciliation of our segment information to the corresponding amounts in the Condensed Consolidated Statements of Net Income is shown in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
|
|
March 31, |
|
|
|
In millions |
|
2025 |
|
2024 |
|
|
|
|
|
TOTAL SEGMENT EBITDA |
|
$ |
1,519
|
|
|
$ |
1,317 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intersegment eliminations and other (1)
|
|
(59) |
|
|
1,255 |
|
(2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Less: |
|
|
|
|
|
|
|
|
|
Interest expense |
|
77
|
|
|
89 |
|
|
|
|
|
|
Depreciation and amortization |
|
266
|
|
|
262 |
|
|
|
|
|
|
INCOME BEFORE INCOME TAXES |
|
$ |
1,117
|
|
|
$ |
2,221 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Included intersegment sales, intersegment profit in inventory and unallocated corporate expenses.
|
|
(2) Included a $1.3 billion gain related the divestiture of Atmus and $14 million of costs associated with the divestiture of Atmus (included in corporate expenses) for the three months ended March 31, 2024. See NOTE 14, "ATMUS DIVESTITURE," for additional information.
|
|
|
|
|